December 2002
Volume 43, Issue 13
ARVO Annual Meeting Abstract  |   December 2002
Scleral Plug of Biodegradable Polymers Containing Immunosuppressant for Experimental Uveitis
Author Affiliations & Notes
  • E Sakurai
    Department of Ophthalmology Nagoya City Univ Medical Sch Mizuho-Ku Japan
  • M Nozaki
    Mizuho-Ku Japan
  • N Kunou
    Mizuho-Ku Japan
  • T Okabe
    Mizuho-Ku Japan
  • H Kimura
    Mizuho-Ku Japan
  • Y Ogura
    Mizuho-Ku Japan
  • Footnotes
    Commercial Relationships   E. Sakurai, None; M. Nozaki , None; N. Kunou , None; T. Okabe , None; H. Kimura , None; Y. Ogura , None. Grant Identification: none
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 2296. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      E Sakurai, M Nozaki, N Kunou, T Okabe, H Kimura, Y Ogura; Scleral Plug of Biodegradable Polymers Containing Immunosuppressant for Experimental Uveitis . Invest. Ophthalmol. Vis. Sci. 2002;43(13):2296.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Abstract: : Purpose: To evaluate the efficacy of a biodegradable scleral plug containing FK-506 in a rabbit model of experimental uveitis. Methods: We prepared the scleral plugs by dissolving poly (DL-lactide-co-glycolide) (PLGA) and FK-506 (weight 8.5mg, length 5mm, 1% FK506). The release of FK-506 was evaluated in vitro by spectrophotometry on days 1, 3, 7, 14, 21, and 35. In vivo, FK-506 concentrations of the aqueous humors and vitreous were measured by high performance liquid chromatography following plug implantation in pigmented rabbits (2, 4, 8, and 12 weeks after intravitreous implantation). Twenty pigmented rabbits were immunized twice subcutaneously with 10mg of Mycobacterium tuberculosis H37Ra antigen. Twelve days later, scleral plugs were implanted into the vitreous of the right eye of 10 rabbits. Ten control rabbits received a sham device. One day after later, the right eye of all rabbits were challenged with an intravitreal injection of 50 µg of antigen. The aqueous protein concentrations and cell counts were determined on post-challenge days 7 and 13. To simulated chronic inflammation, the eyes were rechallenged with intravitreal antigen on day 15 and were observed for 3 months. Inflammation of the anterior chamber and the vitreous were graded clinically by two masked observers. Results: The in vitro release studies showed stable, long term sustained and slow release (released % were 0.78, 1.56, 2.38, 3.06, 20.4, and 39.9 %, respectively). The in vivo release studies showed that the scleral plug had long-term release for vitreous and aqueous humors. Scleral plug was effective in delivering significantly higher drug concentration to each ocular tissues (470-290 ng /g) at all time points. Clinical scores of treated eyes had significantly less inflammation than untreated eyes (P<0.01). Quantitative analysis of inflammatory cells (P<0.01) and protein concentrations (P<0.01) in the anterior chamber showed a significant decrease in treated eyes. After antigen rechallenged, inflammation in experimental eyes was still less than in control eyes. Conclusion: The intravitreal-sustained release of biodegradable polymers containing FK506 device is highly effective in suppressing inflammation experimental uveitis in a rabbit model. This device may be useful in the management of patients with severe chronic uveitis.

Keywords: 612 uveitis-clinical/animal model • 390 drug toxicity/drug effects • 629 vitreous 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.